98 related articles for article (PubMed ID: 2601868)
1. [Cytoprotective effect of rosaprostol during treatment with non-steroidal anti-inflammatory agents in arthrorheumatic pathologies].
Cataldo MG; Sallì L; Scalici G; D'Aiuto A; Bongiorno A; Salerno L
Minerva Dietol Gastroenterol; 1989; 35(3):191-4. PubMed ID: 2601868
[TBL] [Abstract][Full Text] [Related]
2. Effects of a synthetic prostanoid, rosaprostol, on the changes of gastric acidity and digestive disorders induced by NSAID.
Di Murro R; Camarri E; Ciani D; Mariotti L; Nencioni C; Romagnoli AM
Int J Clin Pharmacol Res; 1988; 8(5):345-51. PubMed ID: 3068160
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic rosaprostol treatment of gastro-duodenal disorders caused by corticoid therapy].
Ghiringhelli P
Clin Ter; 1987 Feb; 120(4):309-15. PubMed ID: 2953531
[No Abstract] [Full Text] [Related]
4. [Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2].
Tincani GP; Maniscalco G; Gunelli M; Ciarrocchi V
Minerva Med; 1987 Jun; 78(12):847-53. PubMed ID: 2885786
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term treatment with rosaprostol of patients with gastritis.
Di Simone A; Riegler G; Esposito P; Ciani D
Int J Clin Pharmacol Res; 1988; 8(3):217-21. PubMed ID: 3403108
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of sucralfate in the prevention of stomach diseases induced by non-steroidal anti-inflammatory drugs].
Fioravanti A; Giordano N; Biasi G; Vaccai D; Cataldi V; Marcolongo R
Clin Ter; 1989 Sep; 130(6):333-6. PubMed ID: 2530034
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
Lazzaroni M; Sainaghi M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
9. NSAID and gastropathy: a rheumatologist's review.
Roth SH
J Rheumatol; 1988 Jun; 15(6):912-9. PubMed ID: 3047383
[TBL] [Abstract][Full Text] [Related]
10. Cytoprotective drugs: a new perspective in the treatment of adverse reactions to foods.
Canonica GW; Ciprandi G; Scordamaglia A; Ruffoni S; Pizzorno G; Caria M; Cheli R
Ann Allergy; 1988 Jun; 60(6):541-5. PubMed ID: 2968061
[TBL] [Abstract][Full Text] [Related]
11. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
Parodi MC; Molinari F; Barocci S
Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
[TBL] [Abstract][Full Text] [Related]
13. [Endoscopic study on the gastric tolerance of antalgic-antirheumatic substances:parsalmide].
Mirelli E; Fichera G; Boidi G
Minerva Med; 1976 Oct; 67(52):3361-70. PubMed ID: 1086990
[TBL] [Abstract][Full Text] [Related]
14. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
15. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
[TBL] [Abstract][Full Text] [Related]
16. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
Kordecki H; Kurowski M; Kosik R; Pilecka D
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059
[TBL] [Abstract][Full Text] [Related]
17. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
19. [Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs].
Lazebnik LB; Drozdov VN; Kim VA
Eksp Klin Gastroenterol; 2009; (2):3-9. PubMed ID: 19552017
[TBL] [Abstract][Full Text] [Related]
20. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis.
Galarraga B; Ho M; Youssef HM; Hill A; McMahon H; Hall C; Ogston S; Nuki G; Belch JJ
Rheumatology (Oxford); 2008 May; 47(5):665-9. PubMed ID: 18362100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
